Clinical Trial Update: Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 randomized trial comparing azithromycin plus chloroquine with atovaquone-proguanil for uncomplicated falciparum malaria in South America.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Falciparum Malaria

Drugs mentioned

• Atovaquone-Proguanil (atovaquone-proguanil)
• Azithromycin (azithromycin)
• Chloroquine (chloroquine)

Snippet

Sponsor: Pfizer | Conditions: Malaria, Falciparum | Phase 2, Phase 3 | Status: COMPLETED